The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts
<p>Abstract</p> <p>Background</p> <p>Periodontitis is a bacterial infection of the periodontal tissues. The Gram-negative anaerobic bacterium <it>Porphyromonas gingivalis </it>is considered a major causative agent. One of the virulence factors of <it>P...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-01-01
|
Series: | BMC Microbiology |
Online Access: | http://www.biomedcentral.com/1471-2180/10/5 |
id |
doaj-9522453fbb5a4795a0bd4cdf2969d230 |
---|---|
record_format |
Article |
spelling |
doaj-9522453fbb5a4795a0bd4cdf2969d2302020-11-24T21:59:20ZengBMCBMC Microbiology1471-21802010-01-01101510.1186/1471-2180-10-5The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblastsvan Winkelhoff Arie JLaine Marja LDeng Dong MEl Idrissi Nawal BScheres NinaBrunner JorgCrielaard Wim<p>Abstract</p> <p>Background</p> <p>Periodontitis is a bacterial infection of the periodontal tissues. The Gram-negative anaerobic bacterium <it>Porphyromonas gingivalis </it>is considered a major causative agent. One of the virulence factors of <it>P. gingivalis </it>is capsular polysaccharide (CPS). Non-encapsulated strains have been shown to be less virulent in mouse models than encapsulated strains.</p> <p>Results</p> <p>To examine the role of the CPS in host-pathogen interactions we constructed an insertional isogenic <it>P. gingivalis </it>knockout in the epimerase-coding gene <it>epsC </it>that is located at the end of the CPS biosynthesis locus. This mutant was subsequently shown to be non-encapsulated. K1 capsule biosynthesis could be restored by <it>in trans </it>expression of an intact <it>epsC </it>gene. We used the <it>epsC </it>mutant, the W83 wild type strain and the complemented mutant to challenge human gingival fibroblasts to examine the immune response by quantification of <it>IL-1β</it>, <it>IL-6 </it>and <it>IL-8 </it>transcription levels. For each of the cytokines significantly higher expression levels were found when fibroblasts were challenged with the <it>epsC </it>mutant compared to those challenged with the W83 wild type, ranging from two times higher for IL-1β to five times higher for IL-8.</p> <p>Conclusions</p> <p>These experiments provide the first evidence that <it>P. gingivalis </it>CPS acts as an interface between the pathogen and the host that may reduce the host's pro-inflammatory immune response. The higher virulence of encapsulated strains may be caused by this phenomenon which enables the bacteria to evade the immune system.</p> http://www.biomedcentral.com/1471-2180/10/5 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
van Winkelhoff Arie J Laine Marja L Deng Dong M El Idrissi Nawal B Scheres Nina Brunner Jorg Crielaard Wim |
spellingShingle |
van Winkelhoff Arie J Laine Marja L Deng Dong M El Idrissi Nawal B Scheres Nina Brunner Jorg Crielaard Wim The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts BMC Microbiology |
author_facet |
van Winkelhoff Arie J Laine Marja L Deng Dong M El Idrissi Nawal B Scheres Nina Brunner Jorg Crielaard Wim |
author_sort |
van Winkelhoff Arie J |
title |
The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts |
title_short |
The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts |
title_full |
The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts |
title_fullStr |
The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts |
title_full_unstemmed |
The capsule of <it>Porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts |
title_sort |
capsule of <it>porphyromonas gingivalis </it>reduces the immune response of human gingival fibroblasts |
publisher |
BMC |
series |
BMC Microbiology |
issn |
1471-2180 |
publishDate |
2010-01-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Periodontitis is a bacterial infection of the periodontal tissues. The Gram-negative anaerobic bacterium <it>Porphyromonas gingivalis </it>is considered a major causative agent. One of the virulence factors of <it>P. gingivalis </it>is capsular polysaccharide (CPS). Non-encapsulated strains have been shown to be less virulent in mouse models than encapsulated strains.</p> <p>Results</p> <p>To examine the role of the CPS in host-pathogen interactions we constructed an insertional isogenic <it>P. gingivalis </it>knockout in the epimerase-coding gene <it>epsC </it>that is located at the end of the CPS biosynthesis locus. This mutant was subsequently shown to be non-encapsulated. K1 capsule biosynthesis could be restored by <it>in trans </it>expression of an intact <it>epsC </it>gene. We used the <it>epsC </it>mutant, the W83 wild type strain and the complemented mutant to challenge human gingival fibroblasts to examine the immune response by quantification of <it>IL-1β</it>, <it>IL-6 </it>and <it>IL-8 </it>transcription levels. For each of the cytokines significantly higher expression levels were found when fibroblasts were challenged with the <it>epsC </it>mutant compared to those challenged with the W83 wild type, ranging from two times higher for IL-1β to five times higher for IL-8.</p> <p>Conclusions</p> <p>These experiments provide the first evidence that <it>P. gingivalis </it>CPS acts as an interface between the pathogen and the host that may reduce the host's pro-inflammatory immune response. The higher virulence of encapsulated strains may be caused by this phenomenon which enables the bacteria to evade the immune system.</p> |
url |
http://www.biomedcentral.com/1471-2180/10/5 |
work_keys_str_mv |
AT vanwinkelhoffariej thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts AT lainemarjal thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts AT dengdongm thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts AT elidrissinawalb thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts AT scheresnina thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts AT brunnerjorg thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts AT crielaardwim thecapsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts AT vanwinkelhoffariej capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts AT lainemarjal capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts AT dengdongm capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts AT elidrissinawalb capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts AT scheresnina capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts AT brunnerjorg capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts AT crielaardwim capsuleofitporphyromonasgingivalisitreducestheimmuneresponseofhumangingivalfibroblasts |
_version_ |
1725847753981952000 |